Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_assertion type Assertion NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_head.
- NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_assertion description "[Recently, fully human monoclonal antibodies against GPC3 and mesothelin have been isolated by antibody phage display technology that may provide opportunities for novel cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_provenance.
- NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_assertion evidence source_evidence_literature NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_provenance.
- NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_assertion SIO_000772 21942912 NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_provenance.
- NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_assertion wasDerivedFrom befree-20150227 NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_provenance.
- NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_assertion wasGeneratedBy ECO_0000203 NP427027.RACCa2h-K4Psln8uW7q_T0q144XE9eRensJ2bmpgWeM4s130_provenance.